genetics-investing Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000
genetics-investing Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update
